| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 47.912.856 $ | 96,76 | 302.523 | |||||||
| UNITED THERAPEUTICS CORP | United Therapeutics Corporation | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 3.166.993 $ | 6,40 | 5.543 | |
| CARDINAL HEALTH INC | Cardinal Health, Inc. | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 2.757.605 $ | 5,57 | 14.297 | |
| JAZZ PHARMACEUTICALS PLC | Jazz Pharmaceuticals plc | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 2.601.092 $ | 5,25 | 12.812 | |
| NOVARTIS AG | Novartis A.G. | EC | 66987V109 | Long | Börsenkurs (Stufe 1) | 2.481.514 $ | 5,01 | 16.784 | |
| CENCORA INC | Cencora, Inc. | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 2.474.552 $ | 5,00 | 8.034 | |
| AMGEN INC | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 2.450.411 $ | 4,95 | 7.077 | |
| MCKESSON CORP | McKesson Corporation | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 2.423.590 $ | 4,89 | 2.973 | |
| EXELIXIS INC | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 2.331.705 $ | 4,71 | 52.445 | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 2.305.016 $ | 4,66 | 3.260 | |
| LANTHEUS HOLDINGS INC | Lantheus Holdings, Inc. | EC | 516544103 | Long | Börsenkurs (Stufe 1) | 2.230.160 $ | 4,50 | 26.355 | |
| JOHNSON & JOHNSON | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 1.898.791 $ | 3,83 | 8.261 | |
| BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb Company | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 1.817.700 $ | 3,67 | 30.000 | |
| CIGNA GROUP (THE) | Cigna Group (The) | EC | 125523100 | Long | Börsenkurs (Stufe 1) | 1.758.300 $ | 3,55 | 6.051 | |
| GILEAD SCIENCES INC | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 1.752.078 $ | 3,54 | 13.391 | |
| NATIONAL HEALTHCARE CORP | National HealthCare Corporation | EC | 635906100 | Long | Börsenkurs (Stufe 1) | 1.665.663 $ | 3,36 | 9.612 | |
| VERTEX PHARMACEUTICALS INC | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 1.637.293 $ | 3,31 | 3.831 | |
| INTUITIVE SURGICAL INC | Intuitive Surgical, Inc. | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 1.609.414 $ | 3,25 | 3.517 | |
| MEDPACE HOLDINGS INC | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 1.504.245 $ | 3,04 | 3.593 | |
| MERCK & COMPANY INC | Merck & Company, Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 1.488.014 $ | 3,01 | 13.629 | |
| INCYTE CORP | Incyte Corporation | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 1.477.733 $ | 2,98 | 15.511 | |
| STRYKER CORP | Stryker Corporation | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 1.070.181 $ | 2,16 | 3.396 | |
| LABCORP HOLDINGS INC | Labcorp Holdings, Inc. | EC | 504922105 | Long | Börsenkurs (Stufe 1) | 1.066.490 $ | 2,15 | 4.153 | |
| MEDTRONIC PLC | Medtronic plc | EC | G5960L103 | Long | Börsenkurs (Stufe 1) | 1.000.708 $ | 2,02 | 12.359 | |
| ELI LILLY & COMPANY | Eli Lilly & Company | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 906.562 $ | 1,83 | 970 | |
| NOVO NORDISK A/S | Novo Nordisk A/S | EC | 670100205 | Long | Börsenkurs (Stufe 1) | 840.474 $ | 1,70 | 19.907 | |
| ELEVANCE HEALTH INC | Elevance Health, Inc. | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 610.177 $ | 1,23 | 1.621 | |
| ENSIGN GROUP INC (THE) | Ensign Group, Inc. (The) | EC | 29358P101 | Long | Börsenkurs (Stufe 1) | 586.393 $ | 1,18 | 3.141 | |
| 47.912.856 $ | 96,76 | 302.523 |